Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q8IU60
UPID:
DCP2_HUMAN
Alternative names:
Nucleoside diphosphate-linked moiety X motif 20; mRNA-decapping enzyme 2
Alternative UPACC:
Q8IU60; C9J778; Q6P2D4; Q7Z5W5; Q8NBG5
Background:
The m7GpppN-mRNA hydrolase, also known as mRNA-decapping enzyme 2, is a pivotal decapping metalloenzyme. It catalyzes the removal of the 7-methyl guanine cap from mRNAs, a critical step for mRNA degradation and turnover. This enzyme's activity is essential for normal mRNA decay and nonsense-mediated mRNA decay, highlighting its role in gene expression regulation.
Therapeutic significance:
Understanding the role of m7GpppN-mRNA hydrolase could open doors to potential therapeutic strategies. Its crucial function in mRNA turnover and stability positions it as a key target for modulating gene expression, offering avenues for intervention in diseases where gene expression is dysregulated.